We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Suppression of bone density loss and bone turnover in patients with hormone-sensitive prostate cancer and receiving zoledronic acid.
- Authors
Ryan, Christopher W; Huo, Dezheng; Bylow, Kathryn; Demers, Laurence M; Stadler, Walter M; Henderson, Tara O; Vogelzang, Nicholas J
- Abstract
To report a randomized, placebo-controlled study of treatment with zoledronic acid every 3 months in patients with hormone-sensitive prostate cancer, both with and without bone metastases, to assess the effect on bone mineral density (BMD) and markers of bone turnover.
- Publication
BJU international, 2007, Vol 100, Issue 1, p70
- ISSN
1464-4096
- Publication type
Journal Article
- DOI
10.1111/j.1464-410X.2007.06853.x